Ren et al., 1997 - Google Patents
Human tryptase fibrinogenolysis is optimal at acidic pH and generates anticoagulant fragments in the presence of the anti-tryptase monoclonal antibody B12.Ren et al., 1997
- Document ID
- 16823128551362523102
- Author
- Ren S
- Lawson A
- Carr M
- Baumgarten C
- Schwartz L
- Publication year
- Publication venue
- Journal of immunology (Baltimore, Md.: 1950)
External Links
Snippet
Human tryptase is uniquely regulated by its association with heparin and resists inhibition by biological protease inhibitors. The effects of pH and B12, an IgG anti-tryptase mAb, on cleavage of the synthetic substrate tosyl-Gly-Pro-Lys-p-nitroanilide and of the biological …
- 108060005989 Tryptase family 0 title abstract description 204
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ren et al. | Human tryptase fibrinogenolysis is optimal at acidic pH and generates anticoagulant fragments in the presence of the anti-tryptase monoclonal antibody B12. | |
| Naudin et al. | Factor XII contact activation | |
| Swenson et al. | Snake venom fibrin (ogen) olytic enzymes | |
| Reutelingsperger et al. | Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord | |
| Choi et al. | Thrombolytic, anticoagulant and antiplatelet activities of codiase, a bi-functional fibrinolytic enzyme from Codium fragile | |
| Elrod et al. | Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep | |
| JP4422781B2 (en) | Protease that activates blood coagulation factor VII | |
| Okajima et al. | Effect of protein C and activated protein C on coagulation and fibrinolysis in normal human subjects | |
| Dutta et al. | Anticoagulant mechanism and platelet deaggregation property of a non-cytotoxic, acidic phospholipase A2 purified from Indian cobra (Naja naja) venom: inhibition of anticoagulant activity by low molecular weight heparin | |
| Heeb et al. | Identification of divalent metal ion-dependent inhibition of activated protein C by alpha 2-macroglobulin and alpha 2-antiplasmin in blood and comparisons to inhibition of factor Xa, thrombin, and plasmin. | |
| Mast et al. | Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase | |
| NO164991B (en) | PROCEDURE FOR THE PREPARATION OF BLOOD-COAGULATING INHIBITIVE PROTEINS. | |
| Thakur et al. | A new peptide (Ruviprase) purified from the venom of Daboia russelii russelii shows potent anticoagulant activity via non-enzymatic inhibition of thrombin and factor Xa | |
| Pixley et al. | Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor | |
| Vercauteren et al. | Thrombin activatable fibrinolysis inhibitor: a putative target to enhance fibrinolysis | |
| Strandberg et al. | A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma | |
| Komorowicz et al. | Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors | |
| Machovich et al. | Denatured proteins as cofactors for plasminogen activation | |
| Brazón et al. | Discreplasminin, a plasmin inhibitor isolated from Tityus discrepans scorpion venom | |
| Anonick et al. | Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by α2-antiplasmin, α2-macroglobulin, and antithrombin III in the presence of heparin1 | |
| Bianchini et al. | The proteolytic inactivation of protein z-dependent protease inhibitor by neutrophil elastase might promote the procoagulant activity of neutrophil extracellular traps in sepsis | |
| de Araújo et al. | Purification from Bothrops lanceolatus (fer de lance) venom of a fibrino (geno) lytic enzyme with esterolytic activity | |
| Fonseca et al. | Characterization of a new platelet aggregating factor from crotoxin Crotalus durissus cascavella venom | |
| España et al. | Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma | |
| BANG | Physiology and biochemistry of fibrinolysis |